XML 23 R6.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Condensed Consolidated Statements Of Cash Flows (USD $)
In Thousands
 6 Months Ended
Jul. 02, 2011
Jul. 03, 2010
Operating activities:    
Net income $ 1,475 $ 1,299
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 203 276
Loss on liquidation of foreign subsidiary 170 0
Stock compensation recognized 251 269
Provision for doubtful accounts (12) 0
Provision for inventory reserves 60 150
Changes in operating assets and liabilities:    
Accounts receivable 70 866
Inventories (1,017) (630)
Prepaid expenses and other current assets (22) (82)
Other long term assets (31) 73
Accounts payable 118 141
Accrued compensation (798) (360)
Accrued expenses and deferred rent (300) (474)
Accrued warranty (150) (15)
Deferred revenue 41 (139)
Net cash provided by operating activities 58 1,374
Investing activities:    
Purchases of property and equipment (46) (76)
Purchase of RetinaLabs 0 (225)
Net cash used in investing activities (46) (301)
Financing activities:    
Proceeds from stock option exercises 283 62
Repurchase of common stock (401) 0
Proceeds from borrowings 0 5,876
Repayment of borrowings 0 (9,396)
Net cash used in financing activities (118) (3,458)
Effect of foreign exchange rate changes (33) 7
Net decrease in cash and cash equivalents (139) (2,378)
Cash and cash equivalents at beginning of period 9,014 [1] 9,378
Cash and cash equivalents at end of period 8,875 7,000
Supplemental non-cash activities:    
Contingent consideration - cash 0 380
Shares issued at acquisition 0 444
Contingent consideration - additional shares $ 0 $ 264
[1] Derived from the consolidated audited financial statements included in our annual report filed on Form 10-K with the SEC for the year ended January 1, 2011.